RANBP20P

Across TCGA pan-cancer cohorts, RANBP20P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RANBP20P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RANBP20P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RANBP20P expression acts as an unfavorable survival marker, although some lineages such as LUAD and BRCA show a favorable association.

KICH, CESC, and ESCA are the cancer types where RANBP20P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Quartile	All	0.428	0.934	<.001	56	view →
CESC	OS	Tertile	IV	0.087	0.521	.006	36	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	30	view →
DLBC	OS	Tertile	All	0.472	1.000	.004	29	view →
STAD	OS	Median	IV	0.183	0.570	.007	25	view →
ACC	OS	Tertile	III,IV	0.324	0.673	.018	24	view →
BLCA	DFS	Tertile	All	0.431	0.569	.017	18	view →
LGG	DFS	Median	All	0.682	0.786	.004	17	view →
LUAD	DFS	Tertile	II,III,IV	0.626	0.387	.018	17	view →
SARC	OS	Quartile	All	0.713	0.894	.012	9	view →
UCEC	DFS	Quartile	All	0.540	0.671	.016	8	view →
READ	OS	Tertile	III,IV	0.286	0.732	.014	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RANBP20P–KICH (DFS)

Open the KICH breakdown →